BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 8:53:00 PM | Browse: 837 | Download: 664
Publication Name World Journal of Gastroenterology
Manuscript ID 3216
Country China
Received
2013-04-15 08:36
Peer-Review Started
2013-04-15 15:08
To Make the First Decision
2013-05-14 18:47
Return for Revision
2013-05-19 19:41
Revised
2013-06-17 19:17
Second Decision
2013-07-31 14:33
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-08-01 05:15
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-08-19 15:25
Publish the Manuscript Online
2013-09-09 09:30
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Radiology, Nuclear Medicine & Medical Imaging
Manuscript Type Autobiography
Article Title Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation
Manuscript Source Invited Manuscript
All Author List Gang Cai, Ye Xu, Ji Zhu, Wei-Lie Gu, Shuai Zhang, Xue-Jun Ma, San-Jun Cai and Zhen Zhang
Funding Agency and Grant Number
Corresponding Author Zhen Zhang, MD, Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Xuhui District, Shanghai 200032, China. zhenzhang666@163.com
Key Words Locally advanced rectal cancer; Neoadjuvant chemoradiation; Diffusion-weighted magnetic resonance imaging; Apparent diffusion coefficient
Core Tip This original study prospectively evaluated the clinical value of diffusion-weighted magnetic resonance imaging (DW-MRI) in predicting the response of rectal cancer to neoadjuvant chemoradiation. We found a strong negative correlation between the mean pretreatment tumor apparent diffusion coefficient (ADC) and tumor regression after neoadjuvant chemoradiation, as well as a significant increase in the mean ADC at the 2nd week in the T downstage and tumor regression groups. Therefore, DW-MRI might be a valuable clinical tool to help predict or assess the response of rectal cancer to neoadjuvant chemoradiation at an early timepoint.
Publish Date 2013-09-09 09:30
Citation Cai G, Xu Y, Zhu J, Gu WL, Zhang S, Ma XJ, Cai SJ, Zhang Z. Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation. World J Gastroenterol 2013; 19(33): 5520-5527
URL http://www.wjgnet.com/1007-9327/full/v19/i33/5520.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i33.5520
Full Article (PDF) WJG-19-5520.pdf
Manuscript File 3216-Review.doc
Answering Reviewers 3216-Answering reviewers.pdf
Copyright License Agreement 3216-Copyright assignment.doc
Non-Native Speakers of English Editing Certificate 3216-Language certificate.pdf
Peer-review Report 3216-Peer review(s).pdf
Scientific Editor Work List 3216-Scientific editor work list.doc